Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
-$41,000
Est. net congressional buying / selling (2 years). Updated May 29, 2026

Are Members of Congress Buying or Selling Medpace?

No members of Congress have reported trading Medpace (MEDP) stock in the past 90 days. The history below covers the past two years.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the MEDP AI Score. For corporate insider activity, see MEDP insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading Medpace?

Member of CongressActivityTradesLast Trade
Gilbert Cisneros Sold $49,000 3 Jan 15, 2026
David Taylor Bought $24,000 5 May 15, 2026
Lisa McClain Mixed $16,000 2 Aug 4, 2025

MEDP Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
David Taylor May 15, 2026 Buy $1K – $15K
David Taylor Feb 26, 2026 Buy $1K – $15K
David Taylor Jan 29, 2026 Buy $1K – $15K
David Taylor Jan 16, 2026 Sell $1K – $15K
Gilbert Cisneros Jan 15, 2026 Sell $15K – $50K
Gilbert Cisneros Oct 9, 2025 Sell $1K – $15K
Lisa McClain Aug 4, 2025 Sell $1K – $15K
Gilbert Cisneros Jul 24, 2025 Sell $1K – $15K
David Taylor Jul 23, 2025 Sell $1K – $15K
Lisa McClain Jul 22, 2025 Buy $1K – $15K

Frequently Asked Questions: Medpace Congress Trading

No members of Congress have reported buying or selling MEDP stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

David Taylor bought Medpace (MEDP) stock most recently, on May 15, 2026.

The estimated net value of congressional trades in Medpace over the past 2 years is negative, at -$41,000, meaning members of Congress have on balance sold more than they have bought.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.